PACB Stock Analysis: Buy, Sell, or Hold?
PACB - Pacific Biosciences of California, Inc.
$1.41
-0.24 (-14.55%)
▼
5d:
-11.88%
30d:
+4.44%
90d:
-22.53%
WAIT
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Accumulation
PACB is down 11.9% this week, but smart money is accumulating calls. Top strike: $2 2026-06-18 with 5,522 OI. Call ratio: 88% View Scanner →
Strength: 9.8/10
Get Alerted When PACB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called PACB this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PACB is down 11.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PACB is down 11.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PACB is currently trading at $1.41, which is considered slightly low relative to its 30-day fair value range of $1.39 to $1.66.
Technical Outlook: Technically, PACB is in a downtrend. Immediate support is located at $1.35, while resistance sits at $1.76. Short-term momentum is weak, with the stock down 14.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.38 (+68.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PACB is in a downtrend. Immediate support is located at $1.35, while resistance sits at $1.76. Short-term momentum is weak, with the stock down 14.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.38 (+68.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.39 -
$1.66
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding PACB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-14.5%)
- BULLISH: Trading 68.4% below Wall St target ($2.38)
- WARNING: Recommendation downgraded due to -11.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.39 -
$1.66
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.35
Resistance Level
$1.76
Current Trend
Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.37
Wall Street Target
$2.38
(+68.4%)
Revenue Growth (YoY)
13.8%
Share & Embed Analysis
Last updated: May 09, 2026 12:11 PM ET
Data refreshes hourly during market hours. Next update: 1:11 PM
Data refreshes hourly during market hours. Next update: 1:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PACB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Christian O Henry
SELL
12497 shares
2026-03-03
Michele Farmer
SELL
2979 shares
2026-03-03
Oene Mark Van
SELL
6504 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 59 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 56 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |
Advanced PACB Option Strategies
Professional options setups generated by AI based on today's PACB price and gamma walls.
